Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to -$5.2 million.

  • Usana Health Sciences' Free Cash Flow fell 11901.23% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 7151.82%. This contributed to the annual value of $50.9 million for FY2024, which is 931.13% down from last year.
  • As of Q3 2025, Usana Health Sciences' Free Cash Flow stood at -$5.2 million, which was down 11901.23% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Free Cash Flow registered a high of $37.2 million during Q4 2022, and its lowest value of -$5.2 million during Q3 2025.
  • Its 5-year average for Free Cash Flow is $14.3 million, with a median of $12.7 million in 2025.
  • As far as peak fluctuations go, Usana Health Sciences' Free Cash Flow surged by 28775.55% in 2022, and later crashed by 11901.23% in 2025.
  • Over the past 5 years, Usana Health Sciences' Free Cash Flow (Quarter) stood at $18.1 million in 2021, then soared by 105.84% to $37.2 million in 2022, then tumbled by 49.7% to $18.7 million in 2023, then tumbled by 78.7% to $4.0 million in 2024, then tumbled by 229.53% to -$5.2 million in 2025.
  • Its Free Cash Flow was -$5.2 million in Q3 2025, compared to $7.2 million in Q2 2025 and $12.7 million in Q1 2025.